advisorsecurities master

PGENPrecigen, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
20080
Ticker
PGEN
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2013-08-08
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
PGEN

Detail

Enriched 2026-08-14 20:47

Market cap
$2,452,541,441.95
Shares outstanding (class)
356,510,980
Shares outstanding (weighted)
358,035,247
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
47
Location
GERMANTOWN, MD
Description

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data